Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerNCT06072781VSTMPhase 3Recruiting2028-10-15Estimated
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007NCT06075537DNLIPhase 2, Phase 3Enrolling by invitation2027-06Estimated
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping TreatmentNCT06079736PEPGPhase 2Terminated2025-08-28Actual
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)NCT06081894CytokineticsPhase 3Active not recruiting2026-08-31Actual
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNCT06082167ExelixisPhase 2, Phase 3Active not recruiting2028-08Estimated
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)NCT06087276Praxis Precision MedicinesPhase 3Active not recruiting2025-10-10Actual
DMT310-009 Topical in the Treatment of Acne VulgarisNCT06090721Dermata TherapeuticsPhase 3Completed2025-03-31Actual
A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseNCT06092034RCKTPhase 2Recruiting2028-04Estimated
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung CancerNCT06095505PBYIPhase 2Recruiting2027-10-30Estimated
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisNCT06097260PLRXPhase 2Terminated2025-04-04Actual
Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene TherapyNCT06100887EWTXPhase 2Active not recruiting2027-03Estimated
Global Trial in APG2575 for Patients With CLL/SLLNCT06104566Ascentage Pharma Group Inc.Phase 3Recruiting2026-12-31Estimated
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationNCT06106308Cardiff OncologyPhase 2Active not recruiting2026-11Estimated
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)NCT06108219Corcept TherapeuticsPhase 2Completed2026-02-13Actual
Continuation Study for LatozinemabNCT06111014ALECPhase 3Terminated2025-09-01Actual
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBTNCT06111235CGONPhase 3Active not recruiting2026-11Estimated
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)NCT06112314Immunocore LtdPhase 3Recruiting2027-10-16Estimated
AMX0035 and Progressive Supranuclear PalsyNCT06122662AMLXPhase 2, Phase 3Completed2025-09-30Actual
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant RecipientsNCT06126380Eledon PharmaceuticalsPhase 2Enrolling by invitation2029-12Estimated
A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderNCT06126653AARDPhase 2Completed2025-01-13Actual
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)NCT06127043ANABPhase 2Active not recruiting2026-01Estimated
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT06128369OculisPhase 3Terminated2024-05-02Actual
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)NCT06128629Intellia TherapeuticsPhase 3Recruiting2027-12Estimated
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)NCT06132256Syndax PharmaceuticalsPhase 2Active not recruiting2026-09Estimated
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic DermatitisNCT06136741NKTRPhase 2Active not recruiting2025-05-06Actual
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessNCT06138613Vanda PharmaceuticalsPhase 3Active not recruiting2027-09-30Estimated
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye PressureNCT06144918SKYEPhase 2Completed2024-02-22Actual
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSANCT06146101Incannex Healthcare LtdPhase 2, Phase 3Completed2025-05-20Actual
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCLNCT06149247SoligenixPhase 2Completed2024-05-31Actual
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaNCT06150924MLYSPhase 2Completed2025-02-27Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.